McCrone, Paul https://orcid.org/0000-0001-7001-4502
Everitt, Hazel
Landau, Sabine
Little, Paul
Bishop, Felicity L.
O’Reilly, Gilly
Sibelli, Alice
Holland, Rachel
Hughes, Stephanie
Windgassen, Sula
Goldsmith, Kim
Coleman, Nicholas
Logan, Robert
Chalder, Trudie
Moss-Morris, Rona
Funding for this research was provided by:
Health Technology Assessment Programme (11/69)
Article History
Received: 3 November 2020
Accepted: 14 May 2021
First Online: 6 July 2021
Declaration
:
: The study was approved by the NRES Committee South Central, Berkshire, June 2013 (13/SC/0206). Participants completed an online consent form prior to taking part in the trial.
: Not applicable.
: PL was director of the National Institute for Health Research (NIHR) Programme Grants for Applied Research (PGfAR) and a member of the Journals Library Board. TC reports grants from Guy’s and St Thomas’ Charity. She was a Faculty member, 3rd International Conference on Functional (Psychogenic) Neurological Disorders, Sept 2017, Edinburgh , Member of the IAPT Education and Training ERG (2016-), Member of the IAPT Outcomes and Informatics Meeting (2016), President of the British Association of Behavioural and Cognitive Psychotherapies (2012-2015) for which she did not receive payment. Workshops were delivered on medically unexplained symptoms, during the conduct of the study (money paid into KCL for future research). TC has a patent Background IP - manuals were developed prior to trial starting. SL and KG report grants from NIHR. The TSC Chair, PW, was a colleague of TC in the past but he has recently retired. RMM reports personal fees from training in IBS intervention for Central and North west London NHS Foundation Trust and University of East Anglia outside of the submitted work. Since this study was completed, she has received payment for consultancy to Mahana Therapeutics. Since this study was completed, a private company has signed a licence agreement with King’s College London with the view to bringing the Regul8 website product to the NHS and other international markets. RMM, HE, TC, AS, GOR will be beneficiaries of this licence through contracts with their respective Universities. The patient manual is background IP developed by CI's RMM and TC in previous work. No conflicts of interests for FB, RH, SL, SH, SW, PMc, NC, RL.